Combined revenue from two facilities is approximately $750,000
FREDERICK, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced an expanded relationship with a leading global eye health company that develops and commercializes contact lenses, lens-care products, ophthalmic pharmaceuticals, and surgical technologies for eye-care professionals and patients worldwide.
The customer purchased multiple handheld SteraMist systems for its South Carolina facility in March 2025. A second facility, in Florida, adopted the technology in late 2025. Additional orders in the third quarter of 2026, including SteraMist Environment Systems, brought combined revenue from the two sites to approximately $750,000. The customer has also entered into a recurring BIT Solution purchase agreement, establishing a contracted consumable revenue stream.
The deployment follows a sequence often seen in regulated manufacturing. Customers commonly begin with handheld systems for targeted surface applications, extend use to additional facilities after performance is established, and then evaluate whole-room and integrated systems. This customer has completed the first of those steps and, in the third quarter of 2026, purchased Environment Systems.
Further expansion at both facilities includes additional SteraMist Environment Systems and a CES for complete integrated automated decontamination. TOMI anticipates that some or all of the prospective orders could be received before the end of 2026, which totals in the range of approximately $960,000 to $1.7 million.
“This customer began with handheld units to address a defined operational need. Performance at the first facility supported adoption at a second site,” said James Reynolds, President of ProEx Services and subject matter expert for SteraMist iHP in the Pharma Cleanroom industry. “The discussion has since advanced to additional whole-room systems and integrated automated systems. That progression indicates that the technology has met the customer’s requirements in its own environment and that the relationship now extends beyond the initial purchase.”
“Repeat purchases, a recurring BIT Solution agreement, and active interest in integrated systems from a global manufacturer of this standing are substantive evidence of our ongoing commercial progress,” said Elissa J. (E.J.) Shane, Chief Operating Officer of TOMI Environmental Solutions. “It is the sequence we see in life sciences and manufacturing: demonstrated performance at one site, expansion to another, and recurring BIT Solution revenue from each installation.”
To learn more, contact TOMI at info@tomimist.com or visit SteraMist.com.
About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company providing environmental disinfection and bio-decontamination solutions through manufacturing, sales, and licensing of its Binary Ionization Technology® (BIT®) platform. Developed under a defense grant with DARPA, BIT® utilizes low-percentage hydrogen peroxide to produce ionized hydrogen peroxide (iHP®) fog. SteraMist® products serve hospitals, laboratories, government and military installations, cruise ships, office buildings, schools, restaurants, food processing facilities, and residences, delivering protection against a broad range of bacteria, viruses, mold, mycotoxins, and biological and chemical warfare agents. For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.
Forward-Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s agreement with a leading eye health company and anticipated purchase orders of TOMI’s products. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Zach Nevas
IMS Investor Relations
tomi@imsinvestorrelations.com
